Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tofacitinib Associated With Meglumine Antimoniate in the Control of American Tegumentary Leishmaniasis. A Randomized and Controlled Clinical Trial.

NCT06011343 is registered in ClinicalTrials.gov with Hospital Universitário Professor Edgard Santos as lead sponsor.

NCT NCT06011343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06011343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tofacitinib Associated With Meglumine Antimoniate in the Control of American Tegumentary Leishmaniasis. A Randomized and Controlled Clinical Trial.
Lead sponsor
Hospital Universitário Professor Edgard Santos
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 1, 2023
Completion date
July 1, 2025
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous leishmaniasis, american